Want to see SE:SDOS full AI Analyst Report?
ScandiDos AB (SDOS) AI Stock Analysis
ScandiDos AB
(Nasdaq OMX AB:SDOS)
The score is held down primarily by weak financial performance (declining revenue, ongoing losses, and negative operating/free cash flow). Technicals add further pressure with a clear downtrend and negative momentum, despite oversold readings. Valuation is difficult to support using P/E due to negative earnings and there is no dividend yield data to offset risk.
ScandiDos AB (SDOS) vs. iShares MSCI Sweden ETF (EWD)
- Market Cap
- SEK 39.91M
- Dividend Yield
- ―
- Average Volume (3M)
- 72.72K
- Price to Earnings (P/E)
- -4.6
- Beta (1Y)
- 0.39
- Revenue Growth
- -19.44%
- EPS Growth
- -475.48%
- Country
- Sweden
- Employees
- 25
- Sector
- General
- Sector Strength
- 55
- Industry
- Medical - Devices
ScandiDos AB Business Overview & Revenue Model
Company Description
ScandiDos AB (publ), together with its subsidiaries, provides measurement phantoms and software solutions for the quality assurance and validation of dynamic and modulated treatments adopted in clinics in the United States, Europe, Asia, and internat...
How the Company Makes Money
ScandiDos makes money primarily by selling radiation therapy QA products and related software to hospitals and radiotherapy clinics. Key revenue streams typically include: (1) hardware/system sales of measurement and verification equipment used in ra...
ScandiDos AB Financial Statement Overview
Summary
Weak fundamentals dominate: TTM revenue fell (-8.0%), operating profit and net income remain negative (net margin ~-6.3%), and cash flow is still negative (CFO -2.8m; FCF -4.5m). Offsetting this, the balance sheet is conservatively financed with very low debt relative to equity, and gross margin improved sharply in TTM (~56%), but profitability and self-funding are not yet established.
Income Statement
27NegativeBalance Sheet
63PositiveCash Flow
32Negative| Breakdown | TTM | Apr 2025 | Apr 2024 | Apr 2023 | Apr 2023 | Apr 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 49.97M | 54.22M | 60.43M | 61.55M | 60.43M | 59.99M |
| Gross Profit | 28.15M | -2.71M | 47.55M | 52.95M | 47.55M | 49.73M |
| EBITDA | -5.05M | -439.00K | -11.77M | -3.00M | -11.11M | 2.85M |
| Net Income | -8.21M | -3.44M | -14.65M | -9.12M | -14.65M | -1.40M |
Balance Sheet | ||||||
| Total Assets | 72.08M | 65.97M | 73.38M | 72.42M | 81.47M | 77.16M |
| Cash, Cash Equivalents and Short-Term Investments | 16.00M | 4.36M | 10.06M | 3.55M | 1.53M | 9.00M |
| Total Debt | 2.32M | 0 | 0 | 0 | 0 | 83.00K |
| Total Liabilities | 24.92M | 24.31M | 28.40M | 30.77M | 37.19M | 31.98M |
| Stockholders Equity | 47.16M | 41.66M | 44.98M | 41.65M | 44.29M | 45.18M |
Cash Flow | ||||||
| Free Cash Flow | -4.50M | -6.79M | -2.71M | -16.31M | -1.46M | 4.08M |
| Operating Cash Flow | -2.79M | -2.92M | 230.00K | -11.90M | 1.49M | 8.64M |
| Investing Cash Flow | -3.84M | -3.87M | -2.94M | -4.37M | -2.94M | -4.63M |
| Financing Cash Flow | 11.66M | 0 | 0 | 12.33M | 0 | -1.66M |
ScandiDos AB Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:SDOS, the sentiment is Negative. The current price of 0.56 is below the 20-day moving average (MA) of 0.59, below the 50-day MA of 0.71, and below the 200-day MA of 0.88, indicating a bearish trend. The MACD of -0.04 indicates Negative momentum. The RSI at 31.15 is Neutral, neither overbought nor oversold. The STOCH value of 21.21 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:SDOS.
ScandiDos AB Peers Comparison
Overall Rating
SE:SECT.B74Outperform
SE:PAX60Neutral
SE:SDOS45Neutral
SE:OSSD44Neutral
SE:SPEC40Underperform
SE:SCIB39Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 74Outperform | SEK 67.51B | 105.81 | 30.26% | 0.38% | 13.94% | 5.70% | |
| 60Neutral | SEK 1.54B | -303.85 | -1.22% | ― | 34.05% | -144.96% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 45Neutral | SEK 39.91M | -4.57 | ― | ― | -19.44% | -475.48% | |
| 44Neutral | SEK 373.36M | -7.46 | ― | ― | -2.61% | -0.28% | |
| 40Underperform | SEK 20.68M | -0.12 | -57.15% | ― | ― | 16.02% | |
| 39Underperform | SEK 174.38M | -0.78 | -303.61% | ― | 51.21% | 42.24% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| SE:SDOS | ScandiDos AB | 0.56 | -0.52 | -48.15% | |
| SE:PAX | Paxman AB | 66.30 | -1.10 | -1.63% | |
| SE:SCIB | SciBase Holding AB | 12.35 | -13.24 | -51.74% | |
| SE:SPEC | SpectraCure AB | 0.01 | -0.13 | -90.21% | |
| SE:SECT.B | Sectra AB Class B | 346.00 | 49.17 | 16.56% | |
| SE:OSSD | OssDsign AB | 3.38 | -9.51 | -73.80% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 02, 2026